Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Pablo Ayala de Miguel"'
Autor:
Jose L. Manzano, Juan Martin-Liberal, Luis A. Fernández-Morales, Gretel Benítez, Javier Medina Martínez, María Quindós, Almudena García-Castaño, Ovidio Fernández, Rocío V. Simo, Margarita Majem, Lorena Bellido, Pablo Ayala de Miguel, Begoña Campos, Enrique Espinosa, José A. Macías Cerrolaza, Irene Gil-Arnaiz, David Lorente, Alvaro Rodriguez-Lescure, Victor N. Perez, Rafael López Castro, María G. Gramaje, Teresa Puértolas, Juan F. Rodriguez Moreno, Laia Espasa Font, Guillermo Belaustegui Ferrández, Pablo Cerezuela-Fuentes
Publikováno v:
Melanoma Research.
Autor:
Maria, Gonzalez-Cao, Teresa, Puertolas, Clara, Martinez-Vila, Cristina, Carrera, Cayetana, Maldonado Seral, Pedro, Rodríguez-Jiménez, Silvia, Sequero, Pablo, Cerezuela-Fuentes, Rosa, Feltes Ochoa, Eva, Muñoz, Mónica, Antoñanzas Basa, Juan, Martín-Liberal, Ainara, Soria, Juan, Francisco Rodriguez Moreno, Ivan, Marquez-Rodas, Pilar, Lopez Criado, José, Luis Manzano, Rafael, Lopez-Castro, Pablo, Ayala de Miguel, Laura, Villalobos, Salvador, Martin Algarra, Ines, Gonzalez-Barrallo, Aram, Boada, Almudena, García Castaño, Susana, Puig, Guillermo, Crespo, Pablo, Luna Fra, Cristina, Aguayo Zamora, Marta, Feito Rodríguez, Lara, Valles, Ana, Drozdowskyj, Jesús, Gardeazabal, Luis, Antonio Fernandez-Morales, Alberto, Rodrigo, Raquel, Cruz, Oriol, Yelamos, Belen, Rubio, Karmele, Mujica, Mariano, Provencio, Alfonso, Berrocal
Background The Spanish Melanoma Group (GEM) developed a national registry of patients with melanoma infected by SARS-CoV-2 ( GRAVID ).Methods The main objective was to describe the COVID-19 fatality rate in patients with melanoma throughout the pande
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0f3f41e0e5a020dbbf18dbcc0d240b01
https://hdl.handle.net/10171/65982
https://hdl.handle.net/10171/65982
Publikováno v:
Melanoma Research. 31:268-271
The emerging role of BRAF and MEK tyrosine-kinase inhibitors has shown new opportunities of treatment for patients with advanced melanoma and BRAF mutations. Its use is associated with some toxicities, as pyrexia, that clinicians may not be familiari
Autor:
Juan Manuel Praena-Fernández, Pablo Ayala de Miguel, Jon Cacicedo, Pablo Borrega Garcia, Jose Luis Lopez Guerra, Blas David Delgado, Eleonor Rivin del Campo, Laura Quintana Cortés, María Valle Enguix-Riego, Marco Perez
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
[Background] Small cell lung cancer (SCLC) is one of the greatest therapeutic challenges of oncology. Potential associations between single nucleotide polymorphisms in heat shock protein β1 (HSPB1) and transforming growth factor β1 (TGFβ1) and sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::216b0287904fd04fc1686c2c6d7ab7c9
http://hdl.handle.net/10261/266654
http://hdl.handle.net/10261/266654
Autor:
Ivan Marquez-Rodas, Rosa Feltes Ochoa, Teresa Puertolas, Maria Gonzalez-Cao, Cristina Carrera, Juan Francisco Rodriguez Moreno, Almudena Garcia-Castano, Marta Feito Rodríguez, Ainara Soria, Pablo Ayala de Miguel, Pilar Lopez Criado, Jesús Gardeazabal, Aram Boada, Pablo Luna Fra, Lara Valles, Luis Antonio Fernandez-Morales, Rafael Rosell, Cristina Aguayo Zamora, Mariano Provencio, Laura Villalobos, Alberto Rodrigo, Santiago Viteri, Ana Drozdowskyj, Susana Puig, Juan Martin-Liberal, Guillermo Crespo, Alfonso Berrocal, Cayetana Maldonado-Seral, Jose Luis Manzano, Mónica Antoñanzas Basa, Pedro Rodriguez-Jimenez, Eva Muñoz-Couselo
Publikováno v:
Journal of the American Academy of Dermatology
Autor:
Pedro Rodriguez-Jimenez, Cayetana Maldonado, Alfonso Berrocal, Rosa Feltes, Juan Francisco Rodriguez-Moreno, Lara Valles, Monica Antonazas-Basa, Belen Rubio-Viqueira, Luis Antonio Fernandez-Morales, Pablo Cerezuela, Eva Muñoz-Couselo, Pablo Ayala de Miguel, Jose Luis Manzano, Mariano Provencio, Cristina Aguayo, Teresa Puertolas, Almudena Garcia-Castano, Ivan Marquez-Rodas, Ainara Soria, Marta Feito-Rodríguez, Ana Drozdowskyj, Rafael Rosell, Cristina Carrera, Pilar López-Criado, Guillermo Crespo, Susana Puig, Juan Martin-Liberal, Maria Gonzalez-Cao, Pablo Luna-Fra
Background: Covid-19 pandemic by the new coronavirus SARS-Cov-2 has produced devastating effects on the health care system, affecting also cancer patient care. Data about COVID-19 infection in cancer patients are scarce, and they point out a higher r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17b6ce5a23301a12747175d01abd17b5
https://doi.org/10.1101/2020.05.19.20106971
https://doi.org/10.1101/2020.05.19.20106971
Autor:
Susana Puig, Juan Martin-Liberal, Mónica Antoñanzas Basa, Cristina Aguayo Zamora, Cristina Carrera, Mariano Provencio, Marta Feito Rodríguez, Ainara Soria, Jesús Gardeazabal, Ivan Marquez-Rodas, Alfonso Berrocal, Eva Muñoz, Juan Francisco Rodriguez Moreno, Ana Drozdowskyj, Guillermo Crespo, Pablo Ayala de Miguel, Aram Boada, Teresa Puertolas, Maria Gonzalez-Cao, Pedro Rodriguez-Jimenez, Cayetana Maldonado Seral, Pablo Luna Fra, Jose Luis Manzano, Pilar Lopez Criado, Almudena García Castaño
Publikováno v:
Clinical Cancer Research. 26:PO-059
Background: The COVID-19 pandemic has produced devastating effects on the health care system, also affecting cancer patient care. When the pandemic reached Spain by the end of February 2020, the scarce data about COVID-19 infection in cancer patients
Autor:
Marco Perez, María Valle Enguix-Riego, Pablo Ayala de Miguel, Jose Luis Lopez Guerra, Blas David Delgado, Laura Quintana Cortés, Jon Cacicedo, Eleonor Rivin del Campo, Juan Manuel Praena-Fernández, P. Borrega
Publikováno v:
Journal of Clinical Oncology. 38:e21038-e21038
e21038 Background: Small cell lung cancer (SCLC) is one of the greatest therapeutic challenges of oncology. Potential associations between single-nucleotide polymorphisms (SNP) in Heat shock protein beta- 1 (HSPB1) and Transforming growth factor (TGF
Autor:
Pablo Ayala de Miguel, L. Bellido, Alfonso Berrocal, Lourdes Gutierrez Gutierrez Sanz, Enrique Espinosa, Guillermo Crespo, Pablo Cerezuela Fuentes, Jose Luis Manzano Mozo, Javier Medina, Salvador Martín-Algarra, Almudena García Castaño, Luis Antonio Fernandez-Morales, Margarita Majem, Miguel Angel Berciano Guerrero, Carlos Aguado De La Rosa, Eva Muñoz-Couselo, Rafael López Castro, Ainara Soria, Teresa Puertolas, Ivan Marquez-Rodas
Publikováno v:
Journal of Clinical Oncology. 38:e22022-e22022
e22022 Background: In the past decade, melanoma treatment has improved due to the advances in targeted therapy and immunotherapy. There are few data, however, about the treatment elections and the outcomes of the patients in the real world setting, s
Autor:
Itziar Gorospe García, Pablo Ayala de Miguel, Andrea Posada Restrepo, Alfonso Acero Caballero, Eduardo Ceballos Barbancho, José Manuel Rodríguez García, Rubén Alonso Calderón, Pablo René Rivera Vargas, Andrea Illán Varella, Jonathan Aires Machado, Javier Gallego, Laura Quintana Cortés, Pablo Borrega Garcia
Publikováno v:
Journal of Clinical Oncology. 38:e21662-e21662
e21662 Background: Immunotherapy of cancer has changed the paradigm of treatment of many tumours, specially non-small cell lung cancer (NSCLC). The use of immune-checkpoint inhibitors (ICI) is associated in some patients with the development of new i